Tirzepatide induced larger reductions in body weight vs GLP-1 RAs, ranging from 1.68 kg (95% CI 0.84, 2.52 [ I 2 0%]) with tirzepatide 5 mg to 7.16 kg (95% CI 4.86, 9.46 [ I 2 72%]) with tirzepatide 15 mg (Fig
Women over 40 should be particularly vigilant about maintaining adequate protein intake to prevent excessive muscle loss and monitoring for signs of under-eating (fatigue, hair loss, weakness)
What to Focus On Easy-to-digest options especially if morning nausea or early fullness is an issue
Acid reflux and digestive symptoms are among the known side effects of GLP-1 medications , and for some people, theyre uncomfortable enough to make the medication a poor fit
Here's what we at Klinic recommend considering: Semaglutide might be better if: You have better insurance coverage for it You want a medication with a longer track record You prefer to start with something that might have a slightly gentler introduction period You'd rather take a pill than inject the Wegovy pill makes that possible You've responded well to GLP-1 medications in the past Tirzepatide might be better if: You're looking for maximum weight loss potential You want a medication developed specifically for weight loss You're willing to potentially deal with slightly more nausea initially You want a dual-action approach Your insurance covers it or you have budget flexibility Questions to ask yourself: What's your weight loss goal
Lean mass tends to climb and visceral fat tends to fall, which is where the InBody scan becomes useful for showing real change